📗 Cite This Artifact
Animal Models in Progressive Supranuclear Palsy Research
Animal Models in Progressive Supranuclear Palsy Research
Overview
Animal models are essential tools for understanding the pathogenesis of Progressive Supranuclear Palsy (PSP) and developing therapeutic interventions. Unlike Alzheimer's disease and Parkinson's disease, which have well-established animal models, PSP has presented unique challenges due to the selective vulnerability of specific neuronal populations and the 4R-tau pathology that characterizes the disease. This page provides a comprehensive overview of animal models used in PSP research, including their strengths, limitations, and contributions to our understanding of disease mechanisms.
Why Animal Models Are Critical for PSP Research
Challenges in PSP Modeling
PSP presents several unique challenges that make animal model development particularly difficult:
Research Applications
Animal models enable researchers to:
Animal Models in Progressive Supranuclear Palsy Research
Overview
Animal models are essential tools for understanding the pathogenesis of Progressive Supranuclear Palsy (PSP) and developing therapeutic interventions. Unlike Alzheimer's disease and Parkinson's disease, which have well-established animal models, PSP has presented unique challenges due to the selective vulnerability of specific neuronal populations and the 4R-tau pathology that characterizes the disease. This page provides a comprehensive overview of animal models used in PSP research, including their strengths, limitations, and contributions to our understanding of disease mechanisms.
Why Animal Models Are Critical for PSP Research
Challenges in PSP Modeling
PSP presents several unique challenges that make animal model development particularly difficult:
Research Applications
Animal models enable researchers to:
- Study disease initiation and progression mechanisms
- Test therapeutic interventions before human trials
- Investigate regional vulnerability patterns
- Examine cell-type specific pathology
- Validate biomarkers and therapeutic targets
Rodent Models
Transgenic Mouse Models
P301L Tau Transgenic Models
The P301L mutation in MAPT ( microtubule-associated protein tau) was first identified in frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) and has been extensively used in tauopathy research:
- JNPL3 mice: Express P301L human tau under the prion protein promoter
- Develop neurofibrillary tangles in spinal cord and brainstem
- Show progressive motor dysfunction
- Limited relevance to PSP due to 3R/4R tau mix
- rTg4510 mice: Inducible expression of P301L tau
- Allows temporal control of tau expression
- Shows hippocampal and cortical pathology
- Used for therapeutic intervention studies
4R-Tau Specific Models
Several groups have developed models specifically expressing 4R tau:
- Line 1 (L1) mice: Express human 4R tau with P301L mutation
- Show accumulation of 4R tau in gray matter
- Develop NFT-like pathology in specific brain regions
- Model recapitulates some PSP-like features
- hTau4R mice: Human 4R tau genomic construct
- Human tau coding region with alternative exon 10 inclusion
- Avoids murine tau interference
- Shows age-dependent tau pathology
Knock-in Models
Recent advances have enabled precise genetic knock-in:
- MAPT KI models: Endogenous mouse MAPT replaced with human MAPT variants
- Express physiological levels of tau
- Avoid overexpression artifacts
- Currently being developed for PSP-specific mutations
Rodent PSP Models by Induction
AAV-Mediated Tau Expression
Adeno-associated virus (AAV) vectors allow localized, cell-type specific tau expression:
- AAV-hTau-P301L injection: Direct injection into specific brain regions
- Targets globus pallidus, subthalamic nucleus
- Recreates regional vulnerability patterns
- Useful for studying circuit-specific dysfunction
- AAV-4R tau: Expresses 4R tau isoform specifically
- More closely mimics PSP tau isoform distribution
- Can be targeted to specific neuronal populations
Tau Seed Propagation Models
Recent models exploit the prion-like propagation of tau pathology:
- Inoculation models: Brain homogenate from PSP brains injected into rodents
- Shows templated tau pathology
- Demonstrates strain-specific propagation
- Technical challenges with species barriers
Non-Rodent Mammalian Models
Rabbit Models
Rabbits have been used for tauopathy research due to their closer physiology to humans:
- Tau transgenic rabbits: Express human tau isoforms
- Develop age-dependent tau pathology
- Show some features of 4R tau accumulation
- Useful for studying cerebrovascular interactions
Ferret Models
Ferrets offer advantages for studying brainstem circuitry:
- Natural susceptibility to 4R tau: Ferrets express predominantly 4R tau naturally
- Brainstem architecture: Similar organization to human brainstem nuclei
- Behavioral readouts: Well-characterized motor and cognitive behaviors
Non-Human Primates
Non-human primates (NHPs) provide the closest models to human physiology:
Old World Monkeys
- Cynomolgus macaques: Used for aging studies
- Rhesus macaques: Extensive neuroanatomical characterization
NHP Tauopathy Models
- AAV-mediated tau expression: Targeted injection into NHP brain
- Transgenic NHPs: Limited due to long generation times and ethical considerations
Key Findings from NHP Studies
Invertebrate Models
Caenorhabditis elegans
C. elegans offers rapid, cost-effective modeling:
Tau Transgenic Worms
- Expression of human tau: Pan-neuronal or tissue-specific promoters
- Show tau phosphorylation and aggregation
- Display behavioral deficits
- Used for genetic screens
Advantages
- Rapid generation time (3-4 days)
- Well-characterized nervous system
- Genetic tractability
- Suitable for high-throughput screening
Limitations
- Simplified brain architecture
- Lacks mammalian-specific tau isoforms
- Short lifespan limits age-dependent studies
Drosophila melanogaster
Fruit flies provide powerful genetic tools:
Tau Fly Models
- Expression of human tau isoforms: Using GAL4/UAS system
- Neuron-specific expression possible
- Show tau-induced neurodegeneration
- Behavioral readouts available
Genetic Screens
- Kinase/phosphatase modifiers: Identify modifiers of tau toxicity
- Aggregation inhibitors: Screen for compounds reducing aggregation
- Autophagy modulators: Study protein clearance pathways
PSP-Specific Models
- 4R tau expression: Drosophila can be engineered to express 4R tau
- Mutation studies: Test specific MAPT mutations found in PSP
Zebrafish Models
Zebrafish offer unique advantages for developmental and neurobiological studies:
Tau Transgenic Zebrafish
- Transient expression: mRNA injection for temporary expression
- Stable transgenics: Tissue-specific promoters
- Crisis behavior: High throughput drug screening
Advantages
- Transparent embryos for imaging
- Rapid development
- Genetic conservation with mammals
- Behavioral assays available
Model Comparison
| Model Type | Species | Advantages | Limitations | PSP Relevance |
|------------|---------|------------|-------------|---------------|
| Transgenic mouse | Mouse | Genetic manipulation, aged studies | Mixed 3R/4R tau, overexpression | Moderate |
| AAV injection | Mouse/Rat | Regional targeting, 4R expression | Variable expression | High |
| Knock-in mouse | Mouse | Physiological expression | Long development time | High |
| Rabbit | Rabbit | Intermediate complexity | Limited genetic tools | Moderate |
| Non-human primate | Monkey | Closest to human | Cost, ethics | Very high |
| C. elegans | Worm | Rapid, genetic screens | Simplified system | Low |
| Drosophila | Fly | Genetic tools, screens | Evolutionary distance | Moderate |
| Zebrafish | Fish | Developmental studies | Limited aging studies | Moderate |
Key Pathological Features Recapitulated
Successfully Modeled Features
- NFT-like formations in neurons
- Tau-positive glial inclusions
- Insoluble tau fraction accumulation
- Neuronal loss in targeted regions
- Axonal degeneration
- Synaptic dysfunction
- Gait abnormalities
- Motor coordination deficits
- Reduced locomotor activity
- Microglial activation
- Astrocytosis
- Cytokine expression
Features Not Fully Recapitulated
Therapeutic Testing in Animal Models
Immunotherapy Approaches
Active Immunization
- Tau vaccines: Anti-tau antibody generation
- ACI-35 (phospho-tau vaccine) tested in Phase I/II
- Shows clearance of tau pathology in mouse models
Passive Immunization
- Anti-tau antibodies: Direct antibody administration
- Several antibodies in clinical trials
- Demonstrated efficacy in mouse models
Small Molecule Approaches
- Tau aggregation inhibitors: Methylene blue derivatives
- Kinase inhibitors: GSK-3β, CDK5 inhibitors
- OGA inhibitors: Increase tau O-GlcNAcylation
Gene Therapy Approaches
- Antisense oligonucleotides: Reduce MAPT expression
- Gene editing: CRISPR-based approaches
- Viral vector delivery: Targeted expression of therapeutic proteins
Emerging Models and Future Directions
Humanized Models
- Human tau knock-in mice: Physiological expression
- Chimeric models: Human neurons in mouse brain
- Brain organoids: 3D neural cultures
Strain-Specific Models
- PSP tau strains: Inoculation with patient-derived tau
- Synthetic strains: Defined structural variants
- Strain banking: Repository of characterized strains
Circuit-Specific Models
- Optogenetic models: Light-controlled tau expression
- Chemogenetic models: Designer receptors activated by designer drugs
- Viral tracing: Mapping affected circuits
Cross-Linking
- [Progressive Supranuclear Palsy Pathway](/mechanisms/psp-pathway)
- [Tau Protein](/proteins/tau)
- [Tau Aggregation in PSP](/mechanisms/tau-aggregation-psp)
- [Neuroinflammation in PSP](/mechanisms/neuroinflammation-psp)
- [PSP Selective Neuronal Vulnerability](/mechanisms/selective-neuronal-vulnerability-psp)
- [MAPT Gene](/genes/mapt)
See Also
- [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
- [Tauopathies](/diseases/tauopathies)
- [4R Tauopathies](/diseases/4r-tauopathies)
- [PSP Neuropathology](/mechanisms/psp-neuropathology)
- [Therapeutic Targets in PSP](/therapeutics/psp-therapeutic-targets)
External Links
- [Jackson Laboratory (JAX) - Tauopathy Models](https://www.jax.org/)
- [International Brain Research Organization (IBRO)](https://ibro.org/)
- [Society for Neuroscience](https://www.sfn.org/)
References
Note: This page previously contained references with unverifiable DOIs. References section pending update with verified citations.
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | mechanisms-psp-animal-models |
| kg_node_id | None |
| entity_type | mechanism |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-ce9c09bdb2dc |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'mechanisms-psp-animal-models'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-mechanisms-psp-animal-models?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Animal Models in Progressive Supranuclear Palsy Research](http://scidex.ai/artifact/wiki-mechanisms-psp-animal-models)
http://scidex.ai/artifact/wiki-mechanisms-psp-animal-models